Clinical Trial: Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754279) titled 'Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers' on Aug. 04.

Brief Summary: Open-label, non-comparative, non-randomized clinical trial of the safety and tolerability of the drug MMH-450 in healthy volunteers consisting of 4 consecutive stages

Study Start Date: Feb. 12

Study Type: INTERVENTIONAL

Condition: Cough

Intervention: DRUG: MMH-522

Per os, without food (at least 30 minutes before or after meals and any liquid). The tablet is kept in the mouth until completely dissolved. Duration of therapy - 7 days

Recruitment Status: COMPLETED

Sponsor: Materia Medica Holding

Disclaimer: Curated by HT ...